Skin Examination
A dermatologist or other clinician examines the lesion and may use dermoscopy or clinical photography.
Melanoma Pathology Support
Understanding Your Melanoma Pathology Report
Get a clearer explanation of the diagnosis, melanoma subtype, in situ or invasive disease, Breslow thickness, ulceration, margins, lymph-node findings, and other features documented in your melanoma pathology report.
This educational consultation explains your existing written pathology report. It does not provide a new diagnosis, written report, official document, treatment plan, or replacement for your treating clinicians.
Understand what your report documentsAnd what may still depend on additional surgery, lymph-node evaluation, imaging, or other clinical information.
Board-Certified PathologistProfessional pathology-report guidance
Secure Virtual AppointmentMeet online from the comfort of home
Patient-Friendly ExplanationClear language for complex report findings
Educational SupportNot a replacement for medical advice
Understanding the Process
How a Melanoma Diagnosis Is Established
A skin examination may identify a lesion that needs sampling. A pathologist examines the tissue to determine what is present. Additional excision or lymph-node procedures may later provide more information.
Biopsy
Part or all of the lesion is removed and sent to the pathology laboratory for microscopic examination.
Pathology Diagnosis
The pathologist reports whether melanoma is present and may describe in situ or invasive disease, subtype, and microstaging features.
Additional Surgical Reports
A wide excision or sentinel lymph-node procedure may generate separate reports with additional margin or node findings.
Not every patient has every procedure. The available report depends on the biopsy type, diagnosis, additional surgery, lymph-node evaluation, and stage of care.
Different Reports, Different Questions
Melanoma Biopsy Versus Excision and Lymph-Node Reports
The initial biopsy may establish the diagnosis and document microstaging features. Later procedures may provide additional information about margins, residual melanoma, or sentinel lymph nodes.
Initial Lesion Sample
Melanoma Biopsy Report
A shave, punch, excisional, or other biopsy examines the tissue submitted from the lesion.
- Whether melanoma is present in the sampled tissue
- Melanoma in situ or invasive melanoma
- Histologic subtype when it can be assessed
- Breslow thickness, ulceration, mitotic rate, and other features
- Peripheral and deep margin findings
After Additional Surgery
Wide Excision or Lymph-Node Report
Additional specimens may assess residual melanoma, wider margins, scar tissue, and submitted sentinel or regional lymph nodes.
- Whether residual in situ or invasive melanoma is identified
- Relationship of melanoma to the new surgical margins
- How many lymph nodes were examined
- Whether melanoma was identified in a node
- Features of any documented lymph-node tumor deposit
Inside the Report
What Your Melanoma Pathology Report May Tell You
A melanoma pathology report contains findings that must be understood together. The available detail depends on the specimen, biopsy technique, additional surgery, and testing performed.
A pathology finding should not be interpreted in isolation.
Subtype, thickness, ulceration, mitotic rate, margins, microsatellites, lymph nodes, imaging, and clinical findings may all contribute to the wider assessment.
Diagnosis and Subtype
The diagnosis may describe melanoma in situ or invasive melanoma and may name a specific histologic subtype.
In Situ or Invasive
In situ melanoma remains within the epidermis, while invasive melanoma extends into the dermis or deeper tissue.
Breslow Thickness
For invasive melanoma, this millimeter measurement documents vertical thickness using a defined microscopic method.
Ulceration
The report may state whether the defined microscopic features of ulceration are present or absent.
Mitotic Rate
When reported, mitotic rate describes the number of dividing tumor cells in a defined microscopic area.
Peripheral and Deep Margins
Margins describe whether in situ or invasive melanoma reaches an examined edge of the biopsy or excision.
Additional Tumor Features
Regression, tumor-infiltrating lymphocytes, microsatellites, lymphovascular invasion, or neurotropism may be documented.
Lymph-Node Findings
A separate report may state how many nodes were examined and whether melanoma was identified within them.
Need Help Understanding These Findings?
Review the terminology, key findings, limitations, and pending results in your existing melanoma pathology report during a secure virtual consultation.
EpidermisWhere melanoma in situ is confined
Dermal junctionBoundary with the dermis
DermisWhere invasive melanoma may extend
Subcutaneous tissueDeeper tissue where applicable
Deepest invasive cellUsed in the thickness measurement
Melanoma Microstaging
How In Situ Disease, Invasion, and Breslow Thickness Differ
These terms describe different aspects of the melanoma. Breslow thickness applies to invasive melanoma and contributes to pathologic categorization, but it is not the complete melanoma stage by itself.
Melanoma In Situ
Melanoma cells remain within the epidermis without invasion into the dermis in the examined tissue.
Invasive Melanoma
Melanoma cells extend beyond the epidermis into the dermis or deeper tissue.
Breslow Thickness
The report records the vertical thickness of invasive melanoma in millimeters using a defined microscopic measurement.
Additional Pathology Findings
Features Considered With the Wider Clinical Picture
Melanoma reports may document additional microscopic features considered alongside thickness, ulceration, lymph-node findings, imaging, examination, and other clinical information.
Ulceration
This is a defined microscopic finding involving the epidermis over the melanoma, not simply surface irritation or crusting.
Mitotic Rate
When documented, mitotic rate describes observed tumor-cell division within a defined microscopic area.
Microsatellites
Microsatellites are separate microscopic melanoma deposits near the primary tumor and have a specific pathologic definition.
Lymphovascular Invasion or Neurotropism
The report may document melanoma in lymphatic or blood vessels or describe melanoma involving nerves.
Regression, Tumor-Infiltrating Lymphocytes, and Other Findings
These findings may be reported when present or assessable. Their meaning depends on the complete pathology report and wider clinical context.
Additional Laboratory Studies
Immunohistochemistry, Lymph-Node Studies, and Molecular Testing
These tests have different purposes and may appear in the main pathology report, an addendum, a lymph-node report, or a separate molecular-testing document.
Diagnostic Immunohistochemistry
Additional stains may support classification of a melanocytic lesion or help distinguish melanoma from other findings. They are interpreted with the tissue pattern.
IHCStains
Lymph-Node Studies
Sentinel lymph-node reports may use routine sections and additional stains to evaluate whether melanoma is identified.
NodeIHC
Selected Molecular Testing
BRAF, NRAS, KIT, or other results may appear in a separate report depending on the clinical setting and testing ordered.
BRAFOther
Additional studies do not determine treatment by themselves. Your care team combines pathology, stage, examination, imaging, health history, and other clinical information. A consultation explains what is documented without recommending therapy.
Questions About Additional Stains or Molecular Results?
Get a patient-friendly explanation of the studies already documented in your report and identify which findings may still be pending.
Putting the Results Together
What Is Confirmed, Pending, or Dependent on Other Information?
A melanoma pathology report may answer many important questions, but it may not provide the complete picture on its own.
Confirmed in the Report
Documented Pathology Findings
The diagnosis, subtype, in situ or invasive disease, Breslow thickness, ulceration, mitotic rate, margins, and other features may be documented when the specimen allows.
May Still Be Pending
Addenda or Additional Testing
Additional stains, molecular testing, outside consultation, excision findings, or lymph-node results may still be in progress after the first report is issued.
Requires Wider Context
Complete Stage and Treatment Planning
Complete staging and treatment decisions may also require examination, imaging, additional surgery, laboratory results, and assessment by the treating care team.
How HONEST Pathology Helps
A Clearer Explanation of the Report You Already Have
A pathology report consultation helps you understand terminology and findings already documented, so you can approach conversations with your treating team with greater context and more focused questions.
Upload Your Report and Records
Submit the pathology report and relevant records requested for the consultation.
Meet Online With a Pathologist
Discuss the report during a private virtual appointment and ask questions about the documented findings.
Receive a Plain-Language Explanation
Better understand the terminology and prepare questions to discuss with your treating care team.
Consultation Scope
What the Consultation Includes and Excludes
A report explanation and a formal microscopic second opinion are different services. Clear boundaries help you choose the appropriate option.
The Consultation May Explain
- The documented diagnosis and melanoma terminology
- Differences between biopsy, excision, and lymph-node reports
- In situ versus invasive melanoma and subtype
- Breslow thickness, ulceration, mitotic rate, and margins
- Microsatellites, lymph-node findings, and additional studies already documented
- Findings that remain pending, limited, or included in an addendum
- Questions to discuss with your treating team
The Consultation Does Not Include
- A new pathology diagnosis or replacement interpretation
- A new written report or official document
- Complete staging from the pathology report alone
- Treatment prescribing or replacement of the medical care team
- A physical skin examination or evaluation of lesions not represented in the report
- Microscopic slide review unless a separate pathology second-opinion service is ordered
Choosing the Right Service
Report Consultation or Formal Pathology Second Opinion?
The right option depends on whether you need help understanding written results or an independent review of pathology slides, tissue, or digital images.
Frequently Asked Questions
Questions About Melanoma Pathology Reports
These answers provide general educational information. Individual reports vary according to the specimen, biopsy technique, additional procedures, testing, and wider clinical situation.
What information is included in a melanoma pathology report?
Depending on the specimen, the report may include melanoma subtype, in situ or invasive disease, Breslow thickness, ulceration, mitotic rate, margins, regression, tumor-infiltrating lymphocytes, microsatellites, lymphovascular invasion, neurotropism, and lymph-node findings.
What is the difference between melanoma in situ and invasive melanoma?
Melanoma in situ is documented within the epidermis, while invasive melanoma extends into the dermis or deeper tissue. Treatment and follow-up decisions belong with your medical care team.
What does Breslow thickness mean?
Breslow thickness is the microscopic measurement, in millimeters, of the vertical thickness of invasive melanoma using a defined method. It contributes to pathologic categorization but is not the complete stage by itself.
What does ulceration mean in a melanoma report?
Ulceration is a specifically defined microscopic finding involving loss of the epidermis over the melanoma with associated changes. It is not determined only by whether a lesion looked irritated or crusted.
What does it mean if melanoma reaches a biopsy margin?
It means in situ or invasive melanoma extends to an examined cut edge of the submitted tissue. If invasive melanoma is transected at the deep edge, the biopsy may not show its full thickness.
What information appears in a sentinel lymph-node report?
The report may state how many nodes were examined, whether melanoma was identified, and additional details about any documented tumor deposit. These findings contribute to staging but require the complete clinical record.
Can my report be explained without reviewing the pathology slides?
Yes. A report consultation can explain the written diagnosis, terminology, thickness, ulceration, margins, lymph nodes, additional studies, limitations, and pending findings. It does not provide an independent microscopic diagnosis.
When is a formal pathology second opinion more appropriate?
A formal second opinion may be appropriate when findings are complex, uncertain, unexpected, or when an independent examination of the original slides or tissue could provide additional value.
Clearer Answers Begin Here
Understand the Findings in Your Melanoma Pathology Report
Meet online with a pathologist who can explain the terminology, key findings, measurements, additional studies, and questions raised by your existing report.
Educational support only. This service does not replace your dermatologist, treating physician, surgeon, oncologist, radiologist, genetic counselor, or medical care team.
